BioSpace News Archive

Fresenius Medical Care and Humacyte, Inc. announced a strategic, global partnership and a $150M USD equity investment.

ZappRx announced the ZappRx platform has earned Certified status for information security by HITRUST.

Ferring Pharmaceuticals Inc. (US) has announced findings from a survey conducted with RESOLVE: The National Infertility Association to better understand how men feel when struggling with their own or their partner’s infertility.

Advaxis, Inc., announced it has commenced a Phase 1 trial with the dosing of the first patient with ADXS-NEO, an investigational personalized immunotherapy approach targeting personal neoantigens found by sequencing a patient’s own cancer cells.

Verasense enables surgeons to improve knee balance and customize implant position during surgery by using intraoperative sensor data

Merck KGaA, Darmstadt, Germany announced positive results from two Phase II clinical trials of its investigational, targeted oncology molecule tepotinib[*] in MET-positive, advanced hepatocellular carcinoma (HCC)

SCYNEXIS, Inc. announced the presentation of data at American Society for Microbiology (ASM) Microbe 2018

Dr. Bloch, M.D of Yale University and member of Therapix’s SAB committee, to present Therapix’ s Phase IIa study results in Tourette Syndrome [11-June-2018] TEL AVIV, Israel, June 11, 2018 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (“Therapix” or the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the d

Castlight Health, Inc. announced the following changes to its management team and board of directors.

Medpace Holdings, Inc. announced a secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited